Top Urinalysis Companies

Global Urinalysis Market size was valued at USD 4.28 Billion in 2024 and is poised to grow from USD 4.7 Billion in 2025 to USD 9.85 Billion by 2033, growing at a CAGR of 9.7% during the forecast period (2026–2033).

The global urinalysis market is a highly competitive global market driven by many international competitors. Prominent corporations with cutting-edge AI and ML technology are Google, IBM, Microsoft, and NVIDIA. To support a wide range of applications across industries, these industry experts concentrate on creating cutting-edge algorithms, scalable platforms, and reliable infrastructure. Rapid advances in technology, strategic alliances, and large expenditures on research and development define the competitive environment. 'Roche Diagnostics (Switzerland)', 'Siemens Healthineers AG (Germany) ', 'Beckman Coulter, Inc. (USA) ', 'Sysmex Corporation (Japan) ', 'Abbott Laboratories (USA) ', 'Mindray Bio-Medical Electronics Co., Ltd. (China) ', 'ARKRAY, Inc. (Japan) ', '77 Elektronika Kft. (Hungary) ', 'Dirui Industrial Co., Ltd. (China) ', 'YD Diagnostics Corp. (South Korea) ', 'Bio-Rad Laboratories, Inc. (USA) ', 'Thermo Fisher Scientific Inc. (USA) ', 'Nova Biomedical (USA) ', 'Acon Laboratories, Inc. (USA) ', 'URIT Medical Electronic Co., Ltd. (China) ', 'Macherey-Nagel GmbH & Co. KG (Germany) ', 'Analyticon Biotechnologies AG (Germany) ', 'HUMAN Gesellschaft für Biochemica und Diagnostica mbH (Germany) ', 'Spinreact S.A. (Spain) ', 'Teco Diagnostics (USA)'

The growing cases of chronic diseases like kidney diseases and diabetes is increasing the use and demand for urinalysis on a large scale. These health conditions, if not regularly tested and monitored, may result in more complications. This increases the need for routine monitoring and encourages better patient outcomes. Also, the growing number of UTIs demand better diagnosis via urinalysis, impacting reliable testing services. 

Growth of Product Offerings: The development of improved test strips that can capably notice a broader range of biomarkers and offer more exhaustive outcomes is currently trending in the market. The integration of digital tolls and technologies for data management and analysis considerably improves record-keeping and interpretation. These trends are projected to fuel the urinalysis market.

Geographically, North America dominated the market in the previous years and is expected to lead over the forecast period owing to the presence of advanced healthcare infrastructure and growing cases of chronic illnesses. North America holds well-developed healthcare systems with quality laboratory services and improved diagnostic tools and technologies. Regional growth is also impacted by the growing prevalence of chronic ailments like kidney disorders, diabetes, and urinary infections that demand urinalysis on a large scale. Moreover, a notable emphasis on preventive health measures and routine screenings fuels the need for urinalysis. The key players profiled in the region include Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Becton, Dickinson and Company, Sysmex Corporation, and more.